`

Akamis Bio

Biotechnology Research

Specialities :
Immuno-oncology and re-programming the tumor microenvironment
Sign Up to View More
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$30.0M
size-icon Size
11 - 50
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs

Frequently Asked Questions About Akamis Bio

What does Akamis bio do?+

Akamis is a clinical-stage oncology company whose mission is to leverage its groundbreaking T-SIGn platform to positively impact the lives of people living with cancer. We are developing a portfolio of solid tumor-targeted T-SIGn therapeutics which aim to enable a patients own immune system to recognize, attack, and clear their cancer. Akamis growing pipeline of T-SIGn therapeutics is anchored by its lead clinical-stage program, NG-350A, which is being investigated in an ongoing Phase 1 clinical study in patients with metastatic or advanced epithelial tumors. Akamis has a number of T-SIGn platform-focused collaborations with leaders in the immuno-oncology field including BMS,...

What are Akamis bio's specialties? +

Immuno-oncology and re-programming the tumor microenvironment

What is Akamis bio's industry? +

Akamis bio operates in the Biotechnology research industry.

What is Akamis bio's revenue? +

Akamis bio's revenue is 11m - 100m

What is Akamis bio's company size? +

Akamis bio has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free